CareDx, Inc
CDNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $334 | $280 | $322 | $296 |
| % Growth | 19.1% | -12.9% | 8.6% | – |
| Cost of Goods Sold | $110 | $102 | $112 | $97 |
| Gross Profit | $224 | $178 | $210 | $199 |
| % Margin | 67.2% | 63.6% | 65.1% | 67.1% |
| R&D Expenses | $72 | $82 | $90 | $77 |
| G&A Expenses | $124 | $118 | $100 | $75 |
| SG&A Expenses | $206 | $201 | $196 | $152 |
| Sales & Mktg Exp. | $82 | $83 | $96 | $77 |
| Other Operating Expenses | -$95 | $99 | $0 | $0 |
| Operating Expenses | $183 | $382 | $287 | $229 |
| Operating Income | $41 | -$203 | -$77 | -$30 |
| % Margin | 12.2% | -72.5% | -24% | -10% |
| Other Income/Exp. Net | $12 | $13 | $1 | -$2 |
| Pre-Tax Income | $53 | -$190 | -$76 | -$32 |
| Tax Expense | $0 | $0 | $0 | -$1 |
| Net Income | $53 | -$190 | -$77 | -$31 |
| % Margin | 15.7% | -67.9% | -23.8% | -10.3% |
| EPS | 1 | -3.54 | -1.44 | -0.59 |
| % Growth | 128.2% | -145.8% | -144.1% | – |
| EPS Diluted | 0.93 | -3.54 | -1.44 | -0.59 |
| Weighted Avg Shares Out | 53 | 54 | 53 | 52 |
| Weighted Avg Shares Out Dil | 57 | 54 | 53 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $12 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $20 | $20 | $16 | $12 |
| EBITDA | -$34 | -$85 | -$61 | -$18 |
| % Margin | -10.2% | -30.3% | -19% | -6% |